gemcitabine has been researched along with frondoside a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adem, A; Adrian, TE; Al Shemaili, J; Attoub, S; Collin, P; Hellman, B; Mensah-Brown, E; Nyberg, F; Parekh, K; Thomas, SA | 1 |
| Alsdorf, WH; Avilov, SA; Bokemeyer, C; Dyshlovoy, SA; Hauschild, J; Honecker, F; Kalinin, VI; Madanchi, R; Otte, K; Schumacher, U; Silchenko, AS; Stonik, VA; von Amsberg, G | 1 |
| Arafat, K; Attoub, S; Iratni, R; Khalaf, T; Sulaiman, S | 1 |
3 other study(ies) available for gemcitabine and frondoside a
| Article | Year |
|---|---|
Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Drug Synergism; Gemcitabine; Glycosides; Mice; Mice, Nude; Pancreatic Neoplasms; Triterpenes | 2014 |
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Glycosides; Humans; Sea Cucumbers; Triterpenes; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2017 |
Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Fluorouracil; Gemcitabine; Glycosides; HCT116 Cells; HT29 Cells; Humans; Organoplatinum Compounds; Oxaliplatin; Triterpenes | 2018 |